Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000353621 | SCV000340484 | uncertain significance | not provided | 2016-03-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001088215 | SCV000753284 | benign | Mucopolysaccharidosis, MPS-II | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001088215 | SCV002014459 | uncertain significance | Mucopolysaccharidosis, MPS-II | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001088215 | SCV004235541 | uncertain significance | Mucopolysaccharidosis, MPS-II | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001833368 | SCV002084496 | likely benign | Mucopolysaccharidosis, MPS-III-A | 2020-01-15 | no assertion criteria provided | clinical testing |